Cargando…

Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial

The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jiwon, Oh, Ah-Young, Jeon, Yong-Tae, Koo, Bon-Wook, Kim, Bo Young, Kim, Donghyun, Hwang, Insung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957716/
https://www.ncbi.nlm.nih.gov/pubmed/33804329
http://dx.doi.org/10.3390/jcm10050938
_version_ 1783664713227304960
author Han, Jiwon
Oh, Ah-Young
Jeon, Yong-Tae
Koo, Bon-Wook
Kim, Bo Young
Kim, Donghyun
Hwang, Insung
author_facet Han, Jiwon
Oh, Ah-Young
Jeon, Yong-Tae
Koo, Bon-Wook
Kim, Bo Young
Kim, Donghyun
Hwang, Insung
author_sort Han, Jiwon
collection PubMed
description The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients undergoing laparoscopic cholecystectomy. Eighty patients were randomly assigned to the neostigmine or sugammadex groups. At the end of surgery, neostigmine or sugammadex was administered, and tracheal extubation was performed after confirmation of a train of four ratio ≥ 0.9. The QoR-15 questionnaire was administered at 1 day before surgery and on post-operative days (POD) 1 and 2. The primary outcome was the QoR-15 score on POD 1. The secondary outcomes were the QoR-15 score on POD 2, modified Aldrete score, length of post-anesthetic care unit stay, post-operative pain, administration of anti-emetics, urinary retention, and length of hospital stay. No significant differences were found in QoR-15 scores on POD 1 (94.4 vs. 95.5, p = 0.87) or 2 (116.3 vs. 122, p = 0.33). Secondary outcomes were also comparable, with the exception of urinary retention (15.8% neostigmine vs. 2.6% sugammadex, p = 0.04). This study demonstrated that the quality of recovery was comparable between the neostigmine and sugammadex groups when reversal and tracheal extubation were performed in accordance with the current guidelines.
format Online
Article
Text
id pubmed-7957716
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79577162021-03-16 Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial Han, Jiwon Oh, Ah-Young Jeon, Yong-Tae Koo, Bon-Wook Kim, Bo Young Kim, Donghyun Hwang, Insung J Clin Med Article The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients undergoing laparoscopic cholecystectomy. Eighty patients were randomly assigned to the neostigmine or sugammadex groups. At the end of surgery, neostigmine or sugammadex was administered, and tracheal extubation was performed after confirmation of a train of four ratio ≥ 0.9. The QoR-15 questionnaire was administered at 1 day before surgery and on post-operative days (POD) 1 and 2. The primary outcome was the QoR-15 score on POD 1. The secondary outcomes were the QoR-15 score on POD 2, modified Aldrete score, length of post-anesthetic care unit stay, post-operative pain, administration of anti-emetics, urinary retention, and length of hospital stay. No significant differences were found in QoR-15 scores on POD 1 (94.4 vs. 95.5, p = 0.87) or 2 (116.3 vs. 122, p = 0.33). Secondary outcomes were also comparable, with the exception of urinary retention (15.8% neostigmine vs. 2.6% sugammadex, p = 0.04). This study demonstrated that the quality of recovery was comparable between the neostigmine and sugammadex groups when reversal and tracheal extubation were performed in accordance with the current guidelines. MDPI 2021-03-01 /pmc/articles/PMC7957716/ /pubmed/33804329 http://dx.doi.org/10.3390/jcm10050938 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Han, Jiwon
Oh, Ah-Young
Jeon, Yong-Tae
Koo, Bon-Wook
Kim, Bo Young
Kim, Donghyun
Hwang, Insung
Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title_full Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title_fullStr Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title_full_unstemmed Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title_short Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
title_sort quality of recovery after laparoscopic cholecystectomy following neuromuscular blockade reversal with neostigmine or sugammadex: a prospective, randomized, controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957716/
https://www.ncbi.nlm.nih.gov/pubmed/33804329
http://dx.doi.org/10.3390/jcm10050938
work_keys_str_mv AT hanjiwon qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT ohahyoung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT jeonyongtae qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT koobonwook qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT kimboyoung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT kimdonghyun qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial
AT hwanginsung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial